In a validation study approved by the New York State Department of Health, the AMPIPROBE HCV assay was determined to have the following sensitivity: LOD serum - 5.46 IU/mL via 95% Probit analysis LOD plasma - 7.91 IU/mL via 95% Probit analysis LOQ serum
Target-Kategorie:
Hepatitis virus
Anwendungsbeschreibung:
The AMPIPROBE HCV assay is compatible with any properly calibrated qPCR thermal cycler capable of exciting and reading emissions from FAM/Green and CY5/Red. It has been validated for use on the following instruments: QIAGEN Rotor-Gene Q and Applied Bios
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
